Hill-Rom Holdings, Inc. (HRC) Stake Raised by Bokf Na

Bokf Na lifted its position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 51.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 37,800 shares of the medical technology company’s stock after purchasing an additional 12,919 shares during the period. Bokf Na’s holdings in Hill-Rom were worth $3,347,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund raised its stake in Hill-Rom by 8,755.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 2,281,991 shares in the last quarter. HealthCor Management L.P. acquired a new stake in Hill-Rom during the 3rd quarter worth $76,253,000. Jennison Associates LLC raised its stake in Hill-Rom by 47.0% during the 3rd quarter. Jennison Associates LLC now owns 978,335 shares of the medical technology company’s stock worth $92,355,000 after acquiring an additional 312,771 shares in the last quarter. Select Equity Group L.P. acquired a new stake in Hill-Rom during the 3rd quarter worth $28,996,000. Finally, Bank of New York Mellon Corp raised its stake in Hill-Rom by 27.0% during the 4th quarter. Bank of New York Mellon Corp now owns 1,038,521 shares of the medical technology company’s stock worth $91,961,000 after acquiring an additional 220,981 shares in the last quarter. 84.22% of the stock is owned by institutional investors and hedge funds.

NYSE HRC opened at $104.39 on Thursday. The company has a current ratio of 1.70, a quick ratio of 1.25 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of $7.00 billion, a price-to-earnings ratio of 21.98, a price-to-earnings-growth ratio of 1.81 and a beta of 0.96. Hill-Rom Holdings, Inc. has a one year low of $81.82 and a one year high of $108.10.



Hill-Rom (NYSE:HRC) last posted its quarterly earnings data on Friday, January 25th. The medical technology company reported $1.02 EPS for the quarter, beating analysts’ consensus estimates of $0.98 by $0.04. The company had revenue of $683.50 million for the quarter, compared to analyst estimates of $676.39 million. Hill-Rom had a net margin of 7.21% and a return on equity of 21.23%. Hill-Rom’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.92 earnings per share. Equities analysts anticipate that Hill-Rom Holdings, Inc. will post 5.04 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 22nd will be paid a $0.21 dividend. The ex-dividend date is Thursday, March 21st. This is a positive change from Hill-Rom’s previous quarterly dividend of $0.20. This represents a $0.84 dividend on an annualized basis and a yield of 0.80%. Hill-Rom’s payout ratio is currently 16.84%.

HRC has been the topic of several research analyst reports. UBS Group initiated coverage on shares of Hill-Rom in a research note on Tuesday, November 27th. They set a “buy” rating and a $115.00 price target on the stock. Zacks Investment Research upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating and set a $101.00 price target on the stock in a research note on Wednesday, November 21st. ValuEngine upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating in a research note on Saturday, January 19th. Needham & Company LLC reiterated a “buy” rating and set a $116.00 price target on shares of Hill-Rom in a research note on Monday. Finally, Morgan Stanley cut their price target on shares of Hill-Rom from $100.00 to $98.00 and set an “equal weight” rating on the stock in a research note on Wednesday, January 2nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $103.78.

TRADEMARK VIOLATION WARNING: This piece was reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://dakotafinancialnews.com/2019/03/14/hill-rom-holdings-inc-hrc-stake-raised-by-bokf-na.html.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

See Also: Roth IRA

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.